142 related articles for article (PubMed ID: 10995777)
41. Synergistic activation of the Atlantic salmon hepatocyte nuclear factor (HNF) 1 promoter by the orphan nuclear receptors HNF4 and chicken ovalbumin upstream promoter transcription factor I (COUP-TFI).
McNair A; Cereghini S; Brand H; Smith T; Breillat C; Gannon F
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):557-64. PubMed ID: 11085951
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling.
Lai CF; Feng X; Nishimura R; Teitelbaum SL; Avioli LV; Ross FP; Cheng SL
J Biol Chem; 2000 Nov; 275(46):36400-6. PubMed ID: 10964912
[TBL] [Abstract][Full Text] [Related]
43. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.
Moustakas A; Kardassis D
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6733-8. PubMed ID: 9618481
[TBL] [Abstract][Full Text] [Related]
44. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
Nagarajan RP; Liu J; Chen Y
J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
[TBL] [Abstract][Full Text] [Related]
45. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E; Letamendia A; Attisano L
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.
Choy L; Derynck R
J Biol Chem; 2003 Mar; 278(11):9609-19. PubMed ID: 12524424
[TBL] [Abstract][Full Text] [Related]
47. Orphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter.
Coste H; Rodríguez JC
J Biol Chem; 2002 Jul; 277(30):27120-9. PubMed ID: 12021280
[TBL] [Abstract][Full Text] [Related]
48. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
49. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
Costamagna E; García B; Santisteban P
J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
[TBL] [Abstract][Full Text] [Related]
50. Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter.
Song CZ; Siok TE; Gelehrter TD
J Biol Chem; 1998 Nov; 273(45):29287-90. PubMed ID: 9792626
[TBL] [Abstract][Full Text] [Related]
51. Regulation of Smad7 promoter by direct association with Smad3 and Smad4.
Nagarajan RP; Zhang J; Li W; Chen Y
J Biol Chem; 1999 Nov; 274(47):33412-8. PubMed ID: 10559222
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
53. The role of Sp1 family members, the proximal GC-rich motifs, and the upstream enhancer region in the regulation of the human cell cycle inhibitor p21WAF-1/Cip1 gene promoter.
Koutsodontis G; Moustakas A; Kardassis D
Biochemistry; 2002 Oct; 41(42):12771-84. PubMed ID: 12379120
[TBL] [Abstract][Full Text] [Related]
54. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer.
Jonk LJ; Itoh S; Heldin CH; ten Dijke P; Kruijer W
J Biol Chem; 1998 Aug; 273(33):21145-52. PubMed ID: 9694870
[TBL] [Abstract][Full Text] [Related]
55. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
[TBL] [Abstract][Full Text] [Related]
56. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.
von Gersdorff G; Susztak K; Rezvani F; Bitzer M; Liang D; Böttinger EP
J Biol Chem; 2000 Apr; 275(15):11320-6. PubMed ID: 10753944
[TBL] [Abstract][Full Text] [Related]
57. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
58. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
Poncelet AC; Schnaper HW
J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
[TBL] [Abstract][Full Text] [Related]
59. CCAAT/enhancer-binding protein beta (C/EBP beta) binds and activates while hepatocyte nuclear factor-4 (HNF-4) does not bind but represses the liver-type arginase promoter.
Chowdhury S; Gotoh T; Mori M; Takiguchi M
Eur J Biochem; 1996 Mar; 236(2):500-9. PubMed ID: 8612622
[TBL] [Abstract][Full Text] [Related]
60. Myocardin enhances Smad3-mediated transforming growth factor-beta1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22alpha transcription in vivo.
Qiu P; Ritchie RP; Fu Z; Cao D; Cumming J; Miano JM; Wang DZ; Li HJ; Li L
Circ Res; 2005 Nov; 97(10):983-91. PubMed ID: 16224064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
